A 19-year-old with cystic fibrosis (CF) is aiming to run the London Marathon to raise money for charity and awareness for the ...
Highlights,Sionna Therapeutics has received positive coverage from TD Cowen, Stifel Nicolaus, and Guggenheim.,The stock ...
In a cohort of nearly 300 pediatric patients with cystic fibrosis, food allergy was found in less than 4% of the population, ...
Approximately 1,000 new cases of Cystic Fibrosis are diagnosed each year that bring costly treatments to many families. The life-threatening genetic disorder is ...
IFLScience on MSN13d
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
Infants with cystic fibrosis lack crucial “beneficial bacteria” in their gut, according to new research. Scientists say this ...
Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...
The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in the U.S. currently have it, "though this is likely an ...
Researchers trial inhalable gene therapy for cystic fibrosis, offering a potential breakthrough in treating the genetic lung ...
The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...
Living with cystic fibrosis means constantly navigating the emotional and physical strain of waiting. Despite the exhaustion and uncertainty, waiting reminds us of our ability to endure in the face of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback